Memphis Pathology Laboratory Dba

CLIA Laboratory Citation Details

3
Total Citations
22
Total Deficiencyies
13
Unique D-Tags
CMS Certification Number 26D1105812
Address 1425 Nw Blue Parkway, Lees Summit, MO, 64086
City Lees Summit
State MO
Zip Code64086
Phone(417) 295-3033

Citation History (3 surveys)

Survey - September 15, 2020

Survey Type: Standard

Survey Event ID: HW5S11

Deficiency Tags: D6029 D6029

Summary:

Summary Statement of Deficiencies D6029 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(11) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(11) Ensure that prior to testing patients' specimens, all personnel have the appropriate education and experience, receive the appropriate training for the type and complexity of the services offered, and have demonstrated that they can perform all testing operations reliably to provide and report accurate results. This STANDARD is not met as evidenced by: Based on review of 2019, 2020 competencies and interview with laboratory director, the laboratory director failed to perform one of two initial competencies in 2020. Finding: 1. Review of 2020 initial competencies revealed the laboratory director failed to document competency for testing personnel #1. 2. Interview with laboratory director on September 15, 2020 at 9:30 A.M. confirmed laboratory director failed to document competency on one testing personnel. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - August 17, 2020

Survey Type: Special

Survey Event ID: EG7M11

Deficiency Tags: D2016 D2096 D2097

Summary:

Summary Statement of Deficiencies D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on review of 2019 and 2020 chemistry proficiency testing (PT) results reported to the CLIA database by the PT provider and phone interview with the laboratory director, the laboratory failed to successfully participate in PT. See tags D2096 unsatisfactory performance in two out of three consecutive testing events for the same analyte; D2097 failure to achieve an overall testing event score for chemistry of satisfactory performance for two of three events. D2096 ROUTINE CHEMISTRY CFR(s): 493.841(f) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- Failure to achieve satisfactory performance for the same analyte or test in two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on review of chemistry proficiency testing (PT) results for 2019, 2020 and phone interview with the laboratory director, the laboratory failed to achieve satisfactory performance for the total bilirubin analyte testing in two out of three consecutive PT events. Findings: 1. Review of the chemistry PT results for the third event of 2019 revealed the laboratory obtained an unsatisfactory score of 0 percent for the analyte, total bilirubin. 2. Review of the chemistry PT results for the second event of 2020 revealed the laboratory obtained an unsatisfactory score of 0 percent for total bilirubin. 3. Phone interview with the laboratory director on August 12, 2020 at 10:30 AM confirmed the laboratory failed to achieve satisfactory performance for total bilirubin testing in two out of three consecutive events for 2019, 2020. D2097 ROUTINE CHEMISTRY CFR(s): 493.841(g) Failure to achieve an overall testing event score of satisfactory performance for two consecutive testing events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on review of chemistry proficiency testing (PT) results for 2019, 2020 and phone interview with the laboratory director, the laboratory failed to achieve satisfactory performance for the specialty of chemistry in two out of three consecutive PT events. Findings: 1. Review of the chemistry PT results for the third event of 2019 revealed the laboratory obtained an unsatisfactory score of 0 percent for the specialty of chemistry. 2. Review of the chemistry PT results for the second event of 2020 revealed the laboratory obtained an unsatisfactory score of 0 percent for the specialty of chemistry. 3. Phone interview with the laboratory director on August 12, 2020 at 10: 30 AM confirmed the laboratory failed to achieve satisfactory performance for the specialty of chemistry in two out of three consecutive events for 2019, 2020. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 30, 2018

Survey Type: Standard

Survey Event ID: 15DC11

Deficiency Tags: D5403 D5421 D5807 D6021 D6028 D6056 D6057 D6062 D5421 D5469 D5469 D5807 D6021 D6028 D6056 D6057 D6062

Summary:

Summary Statement of Deficiencies D5403 PROCEDURE MANUAL CFR(s): 493.1251(b) The procedure manual must include the following when applicable to the test procedure: (1) Requirements for patient preparation; specimen collection, labeling, storage, preservation, transportation, processing, and referral; and criteria for specimen acceptability and rejection as described in 493.1242. (2) Microscopic examination, including the detection of inadequately prepared slides. (3) Step-by-step performance of the procedure, including test calculations and interpretation of results. (4) Preparation of slides, solutions, calibrators, controls, reagents, stains, and other materials used in testing. (5) Calibration and calibration verification procedures. (6) The reportable range for test results for the test system as established or verified in 493.1253. (7) Control procedures. (8)

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access